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background:  There are limited data on the use of prescription drug programs among older patients (pts) with acute myocardial infarction 
(AMI), as well as the association of program participation with downstream outcomes.
methods:  Using Medicare records linked to ACTION Registry-GWTG, we identified 59,149 AMI pts ≥ age 65 discharged between 1/2007 
and 12/2010. We used inverse probability weighted propensity methods to compare 30-day and 1-year risks of all-cause death; all-cause 
readmissions; and major adverse cardiac events (MACE, a composite of death or readmission for AMI or stroke) between Part D enrollees 
and non-enrollees.
Results:  From 2007-2010, 29,264 (49.5%) AMI pts were enrolled in Medicare Part D by hospital discharge. At discharge, rates of statin, 
beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and P2Y12 inhibitor use were similar among enrollees 
and non-enrollees, yet adherence to these therapies was low (55%-64%) at 1 year post-discharge among Part D enrollees. Part D 
enrollees had higher observed rates of death, readmission, and MACE, but these differences were attenuated and not clinically significant 
after adjustment (Table).
conclusion:  Only half of Medicare-insured pts with AMI were enrolled in Part D by hospital discharge, and their 30-day and 1-year 
adjusted outcomes did not differ substantially from non-enrollees. There remain opportunities for improvement in medication adherence 
among pts with prescription drug coverage.
Table: Cumulative incidence of 30-day and 1-year outcomes among acute myocardial infarction patients enrolled versus not enrolled in 
Medicare Part D
Outcome Events (cumulative incidence, %)
Unadjusted 
hazard ratio
(95% confidence interval)
Adjusted* 
hazard ratio
(95% confidence interval)
Enrolled in Part D Not enrolled in Part D
All-cause mortality within 30 days 1150 (4.0%) 966 (3.3%) 1.22 (1.13-1.32) 1.06 (0.98-1.16)
All-cause readmission within 30 
days 5166 (17.9%) 4562 (15.4%) 1.17 (1.13-1.22) 1.04 (1.00-1.09)
MACE within 30 days 1692 (5.9%) 1490 (5.0%) 1.16 (1.09-1.24) 1.02 (0.96-1.10)
All-cause mortality within 1 year 4718 (18.5%) 4024 (15.4%) 1.22 (1.17-1.28) 1.06 (1.01-1.11)
All-cause readmission within 1 year 13632 (51.9%) 12591 (47.2%) 1.16 (1.13-1.19) 1.05 (1.02-1.07)
MACE within 1 year 6246 (24.5%) 5474 (21.0%) 1.19 (1.15-1.24) 1.03 (0.99-1.07)
* Adjusted models were developed using inverse probability weighted methods. Covariates included: age; sex; race; body-mass index; five indicators of socioeconomic status derived from patients’ zip codes and U.S. 
census data (percent persons age ≥ 25 years with ≥ 4 years of college, percent persons age ≥ 25 years with a high school diploma, percent white collar workers, median estimated household income, and median 
home value); number of hospitalizations in the prior 12 months; transfer-in status; ST-segment elevation on presenting electrocardiogram; cardiogenic shock; signs of heart failure; systolic blood pressure; heart rate; 
history of hypertension; diabetes mellitus; peripheral arterial disease; current or recent smoker; prior myocardial infarction; prior percutaneous coronary intervention; prior coronary artery bypass graft surgery; prior heart 
failure; prior stroke; dialysis; Charlson comorbidity index; home medications (aspirin, P2Y12 inhibitor, beta blocker, ACE inhibitor or angiotensin receptor blocker, and statin); baseline creatinine and troponin (ratio over 
institutional upper limit of normal); in-hospital left ventricular ejection fraction; reperfusion therapy use among STEMI patients; revascularization among NSTEMI patients; hospital region; and hospital teaching status.
